Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

Cánula para microinyección ocular

Resumen

Tipo:
Oferta Tecnológica
Referencia:
TODE20171103001
Publicado:
20/11/2017
Caducidad:
20/11/2018
Resumen:
Una empresa alemana especializada en comercializar tecnologías innovadoras procedentes de 33 institutos de investigación de Bavaria ofrece los derechos de propiedad intelectual de una tecnología médica. Se trata de una cánula para microinyección ocular que se utiliza en inyecciones intra y subretinales para curar la degeneración macular asociada con la edad (AMD). La tecnología también puede aplicarse en otras patologías, como oclusión de las venas retinianas y enfermedades de la retina. Este sistema es el único que permite la inyección/succión intra y subretinal con un solo grado de libertad para el avance del catéter. La empresa busca socios con el fin de establecer acuerdos de licencia.

Details

Tittle:
Cannula for Ocular Micro-Injection
Summary:
A German company, which is active in commercializing innovations from 33 research institutes in Bavaria, offers intellectual property rights (IPR) for a medical technology:
A cannula for ocular micro-injection, which can be addressed for targeted intra- and sub-retinal injections to cure age-related macular degeneration (AMD).They are looking for interested parties to enter into a licensing agreement.
Description:
The primary, but not the only, application of this cannula is intra- and sub-retinal targeted administration of drugs and stem-cells to cure age-related macular degeneration (AMD). The other pathologies such as retinal vein occlusion and retinal diseases are alternative applications of this technology. A catheter principle is addressing a serious clinical challenge in ocular micro-injection which is the lack of ergonomic positioning for inserting a bent-tip needle with appropriate position and orientation.To facilitate efficient treatment of both forms of AMD, ophthalmologists suggested targeted delivery of sub-retinal substances. The technology helps to facilitate efficient treatment of AMD by a targeted delivery of intra- and sub-retinal substances. AMD patients, the first and direct target group with 8.7 % prevalence among people older than 45 can benefit from this newly invented system. AMD is the leading cause of blindness in developed countries and this disease is expanding from 178 million cases in 2014 to 196 million cases in 2020.
The current utilities were up to now not appropriate for such an injection.
This cannula system is the only one which comprises intuitive and ergonomic intra- and sub-retinal injection/suction with only one degree of freedom (DOF) for catheter advancement. Therefore the system enables a very high precision. The technology has already been prototyped with larger diameter and it has been tested by eye surgeons on pig eyes under OCT integrated ophthalmic microscope. They are now looking for industry partners in the field of ophthalmological surgery instruments to licence this new technology.
Advantages and Innovations:
- New cannula system is designed to address targeted intra- and sub-retinal injection
- Only cannula comprising intuitive and ergonomic intra- and sub-retinal injection with only one degree of freedom (DOF) for catheter advancement
- Two-channel system provides very high precision

Stage of Development:
Prototype available for demonstration
IPs:
Patent(s) applied for but not yet granted
CommeR Statunts Regarding IPR Status:
A PCT application is pending.

Partner sought

Type and Role of Partner Sought:
The agency looks for industry partners in the field of ophthalmological surgery instruments to licence this new technology.

Client

Type and Size of Client:
University
Already Engaged in Trans-National Cooperation:
Si
Languages Spoken:
English
German

Keywords

Technology Keywords:
06001017 Cirugía